Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$2.3K
4 trades · 2 insiders
Net · 90d
$-2.3K
Insiders on file
15
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Leverone Jason A. | Chief Financial Officer | 29 | $0 | $16.0K | 2026-09-21 |
| Saccomano Nicholas A | President and CEO, Director | 39 | $0 | $4.5K | 2026-09-21 |
| Hartley Dylan | Chief Scientific Officer | 9 | $0 | $0 | 2026-08-07 |
| Phillips Andrew John | Director | 5 | $0 | $0 | 2026-08-07 |
| Jansen Valerie Malyvanh | Director | 5 | $0 | $0 | 2026-08-07 |
| Agresta Samuel | Chief Medical Officer | 14 | $0 | $0 | 2026-08-07 |
| Carruthers R Michael | Director | 9 | $0 | $0 | 2026-08-07 |
| Manke Isaac | Director | 12 | $0 | $0 | 2026-08-07 |
| Ratcliffe Liam | Director | 4 | $0 | $0 | 2026-08-07 |
| Mathers Edward T | Director | 9 | $0 | $0 | 2026-08-07 |
| GREY MICHAEL G | Director | 5 | $0 | $0 | 2026-08-07 |
| Cormorant Private Healthcare Fund III LP | Other | 1 | $0 | $3.35M | 2025-05-15 |
| ACORN CAPITAL ADVISORS GP, LLC | 10% Owner | 2 | $2.59M | $0 | 2025-05-15 |
| Cormorant Global Healthcare Master Fund, LP | 10% Owner | 1 | $0 | $48.4K | 2025-05-12 |
| Leonard Braden Michael | Other | 2 | $0 | $0 | 2024-10-07 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Leverone Jason A. | Chief Financial Officer | S Sale | 2026-09-21 | 2026-09-23 | 302 | $2.97 | $897 | 18,500 | SEC↗ |
| Saccomano Nicholas A | President and CEO | S Sale | 2026-09-21 | 2026-09-23 | 87 | $2.97 | $258 | 11,160 | SEC↗ |
| Saccomano Nicholas A | President and CEO, Director | S Sale | 2026-09-21 | 2026-09-23 | 87 | $2.97 | $259 | 11,160 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | S Sale | 2026-09-21 | 2026-09-23 | 302 | $2.97 | $898 | 18,500 | SEC↗ |
| Agresta Samuel | Chief Medical Officer | D To issuer deriv | 2026-08-07 | 2026-08-11 | 18,588 | — | $0 | 0 | SEC↗ |
| Agresta Samuel | Chief Medical Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Agresta Samuel | Chief Medical Officer | D To issuer deriv | 2026-08-07 | 2026-08-11 | 131,396 | — | $0 | 0 | SEC↗ |
| Agresta Samuel | Chief Medical Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 18,588 | — | $0 | 18,588 | SEC↗ |
| Agresta Samuel | Chief Medical Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 131,396 | — | $0 | 131,396 | SEC↗ |
| Hartley Dylan | Chief Scientific Officer | D To issuer deriv | 2026-08-07 | 2026-08-11 | 137,603 | — | $0 | 0 | SEC↗ |
| Hartley Dylan | Chief Scientific Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Hartley Dylan | Chief Scientific Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 137,603 | — | $0 | 137,603 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 5,322 | — | $0 | 5,322 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 5,781 | — | $0 | 5,781 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | D To issuer deriv | 2026-08-07 | 2026-08-11 | 5,781 | — | $0 | 0 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | D To issuer deriv | 2026-08-07 | 2026-08-11 | 130,611 | — | $0 | 0 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 130,611 | — | $0 | 130,611 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | D To issuer deriv | 2026-08-07 | 2026-08-11 | 5,322 | — | $0 | 0 | SEC↗ |
| Saccomano Nicholas A | President and CEO | D To issuer deriv | 2026-08-07 | 2026-08-11 | 8,449 | — | $0 | 0 | SEC↗ |
| Saccomano Nicholas A | President and CEO | A Award deriv | 2026-08-07 | 2026-08-11 | 1,485 | — | $0 | 1,485 | SEC↗ |
| Saccomano Nicholas A | President and CEO | D To issuer deriv | 2026-08-07 | 2026-08-11 | 1,485 | — | $0 | 0 | SEC↗ |
| Saccomano Nicholas A | President and CEO | A Award deriv | 2026-08-07 | 2026-08-11 | 2,359 | — | $0 | 2,359 | SEC↗ |
| Saccomano Nicholas A | President and CEO | D To issuer deriv | 2026-08-07 | 2026-08-11 | 2,359 | — | $0 | 0 | SEC↗ |
| Saccomano Nicholas A | President and CEO | A Award deriv | 2026-08-07 | 2026-08-11 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Saccomano Nicholas A | President and CEO | A Award deriv | 2026-08-07 | 2026-08-11 | 542,232 | — | $0 | 542,232 | SEC↗ |
| Saccomano Nicholas A | President and CEO | D To issuer deriv | 2026-08-07 | 2026-08-11 | 542,232 | — | $0 | 0 | SEC↗ |
| Saccomano Nicholas A | President and CEO | A Award deriv | 2026-08-07 | 2026-08-11 | 16,898 | — | $0 | 16,898 | SEC↗ |
| Saccomano Nicholas A | President and CEO | D To issuer deriv | 2026-08-07 | 2026-08-11 | 16,898 | — | $0 | 0 | SEC↗ |
| Saccomano Nicholas A | President and CEO | A Award deriv | 2026-08-07 | 2026-08-11 | 8,449 | — | $0 | 8,449 | SEC↗ |
| Carruthers R Michael | Director | A Award deriv | 2026-08-07 | 2026-08-11 | 22,350 | — | $0 | 22,350 | SEC↗ |
| GREY MICHAEL G | Director | A Award deriv | 2026-08-07 | 2026-08-11 | 22,350 | — | $0 | 22,350 | SEC↗ |
| Jansen Valerie Malyvanh | Director | A Award deriv | 2026-08-07 | 2026-08-11 | 22,350 | — | $0 | 22,350 | SEC↗ |
| Manke Isaac | Director | D To issuer deriv | 2026-08-07 | 2026-08-11 | 15,300 | — | $0 | 0 | SEC↗ |
| Manke Isaac | Director | A Award deriv | 2026-08-07 | 2026-08-11 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Manke Isaac | Director | A Award deriv | 2026-08-07 | 2026-08-11 | 15,300 | — | $0 | 15,300 | SEC↗ |
| Phillips Andrew John | Director | A Award deriv | 2026-08-07 | 2026-08-11 | 22,350 | — | $0 | 22,350 | SEC↗ |
| Ratcliffe Liam | Director | A Award deriv | 2026-08-07 | 2026-08-11 | 22,350 | — | $0 | 22,350 | SEC↗ |
| Mathers Edward T | Director | A Award deriv | 2026-08-07 | 2026-08-11 | 22,350 | — | $0 | 22,350 | SEC↗ |
| Phillips Andrew John | Director | A Award deriv | 2026-08-07 | 2026-08-11 | 22,350 | — | $0 | 22,350 | SEC↗ |
| Saccomano Nicholas A | President and CEO, Director | A Award deriv | 2026-08-07 | 2026-08-11 | 542,232 | — | — | 542,232 | SEC↗ |
| Saccomano Nicholas A | President and CEO, Director | D To issuer deriv | 2026-08-07 | 2026-08-11 | 542,232 | — | — | 0 | SEC↗ |
| Saccomano Nicholas A | President and CEO, Director | A Award deriv | 2026-08-07 | 2026-08-11 | 16,898 | — | — | 16,898 | SEC↗ |
| Saccomano Nicholas A | President and CEO, Director | D To issuer deriv | 2026-08-07 | 2026-08-11 | 16,898 | — | — | 0 | SEC↗ |
| Saccomano Nicholas A | President and CEO, Director | A Award deriv | 2026-08-07 | 2026-08-11 | 8,449 | — | — | 8,449 | SEC↗ |
| Saccomano Nicholas A | President and CEO, Director | D To issuer deriv | 2026-08-07 | 2026-08-11 | 8,449 | — | — | 0 | SEC↗ |
| Saccomano Nicholas A | President and CEO, Director | A Award deriv | 2026-08-07 | 2026-08-11 | 1,485 | — | — | 1,485 | SEC↗ |
| Saccomano Nicholas A | President and CEO, Director | D To issuer deriv | 2026-08-07 | 2026-08-11 | 1,485 | — | — | 0 | SEC↗ |
| Saccomano Nicholas A | President and CEO, Director | A Award deriv | 2026-08-07 | 2026-08-11 | 2,359 | — | — | 2,359 | SEC↗ |
| Saccomano Nicholas A | President and CEO, Director | D To issuer deriv | 2026-08-07 | 2026-08-11 | 2,359 | — | — | 0 | SEC↗ |
| Saccomano Nicholas A | President and CEO, Director | A Award deriv | 2026-08-07 | 2026-08-11 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Ratcliffe Liam | Director | A Award deriv | 2026-08-07 | 2026-08-11 | 22,350 | — | $0 | 22,350 | SEC↗ |
| Mathers Edward T | Director | A Award deriv | 2026-08-07 | 2026-08-11 | 22,350 | — | $0 | 22,350 | SEC↗ |
| Manke Isaac | Director | A Award deriv | 2026-08-07 | 2026-08-11 | 15,300 | — | — | 15,300 | SEC↗ |
| Manke Isaac | Director | D To issuer deriv | 2026-08-07 | 2026-08-11 | 15,300 | — | — | 0 | SEC↗ |
| Manke Isaac | Director | A Award deriv | 2026-08-07 | 2026-08-11 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 130,611 | — | — | 130,611 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | D To issuer deriv | 2026-08-07 | 2026-08-11 | 130,611 | — | — | 0 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 5,322 | — | — | 5,322 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | D To issuer deriv | 2026-08-07 | 2026-08-11 | 5,322 | — | — | 0 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 5,781 | — | — | 5,781 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | D To issuer deriv | 2026-08-07 | 2026-08-11 | 5,781 | — | — | 0 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Jansen Valerie Malyvanh | Director | A Award deriv | 2026-08-07 | 2026-08-11 | 22,350 | — | $0 | 22,350 | SEC↗ |
| Hartley Dylan | Chief Scientific Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 137,603 | — | — | 137,603 | SEC↗ |
| Hartley Dylan | Chief Scientific Officer | D To issuer deriv | 2026-08-07 | 2026-08-11 | 137,603 | — | — | 0 | SEC↗ |
| Hartley Dylan | Chief Scientific Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| GREY MICHAEL G | Director | A Award deriv | 2026-08-07 | 2026-08-11 | 22,350 | — | $0 | 22,350 | SEC↗ |
| Carruthers R Michael | Director | A Award deriv | 2026-08-07 | 2026-08-11 | 22,350 | — | $0 | 22,350 | SEC↗ |
| Agresta Samuel | Chief Medical Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 131,396 | — | — | 131,396 | SEC↗ |
| Agresta Samuel | Chief Medical Officer | D To issuer deriv | 2026-08-07 | 2026-08-11 | 131,396 | — | — | 0 | SEC↗ |
| Agresta Samuel | Chief Medical Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 18,588 | — | — | 18,588 | SEC↗ |
| Agresta Samuel | Chief Medical Officer | D To issuer deriv | 2026-08-07 | 2026-08-11 | 18,588 | — | — | 0 | SEC↗ |
| Agresta Samuel | Chief Medical Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | S Sale | 2026-06-22 | 2026-06-24 | 303 | $4.40 | $1.3K | 18,802 | SEC↗ |
| Saccomano Nicholas A | President and CEO | S Sale | 2026-06-22 | 2026-06-24 | 86 | $4.40 | $378 | 11,247 | SEC↗ |
| Carruthers R Michael | Director | A Award deriv | 2026-06-04 | 2026-06-08 | 7,650 | — | $0 | 7,650 | SEC↗ |
| GREY MICHAEL G | Director | A Award deriv | 2026-06-04 | 2026-06-08 | 7,650 | — | $0 | 7,650 | SEC↗ |
| Jansen Valerie Malyvanh | Director | A Award deriv | 2026-06-04 | 2026-06-08 | 7,650 | — | $0 | 7,650 | SEC↗ |
| Phillips Andrew John | Director | A Award deriv | 2026-06-04 | 2026-06-08 | 7,650 | — | $0 | 7,650 | SEC↗ |
| Ratcliffe Liam | Director | A Award deriv | 2026-06-04 | 2026-06-08 | 1,275 | — | $0 | 1,275 | SEC↗ |
| Mathers Edward T | Director | A Award deriv | 2026-06-04 | 2026-06-08 | 7,650 | — | $0 | 7,650 | SEC↗ |
| Agresta Samuel | Chief Medical Officer | A Award deriv | 2026-04-01 | 2026-04-03 | 110,000 | — | $0 | 110,000 | SEC↗ |
| Hartley Dylan | Chief Scientific Officer | A Award deriv | 2026-04-01 | 2026-04-03 | 110,000 | — | $0 | 110,000 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | A Award deriv | 2026-04-01 | 2026-04-03 | 110,000 | — | $0 | 110,000 | SEC↗ |
| Saccomano Nicholas A | President and CEO | A Award deriv | 2026-04-01 | 2026-04-03 | 330,000 | — | $0 | 330,000 | SEC↗ |
| Ratcliffe Liam | Director | A Award deriv | 2026-03-31 | 2026-04-01 | 15,300 | — | $0 | 15,300 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | S Sale | 2026-03-23 | 2026-03-24 | 301 | $4.16 | $1.3K | 16,000 | SEC↗ |
| Saccomano Nicholas A | President and CEO | S Sale | 2026-03-23 | 2026-03-24 | 86 | $4.16 | $358 | 7,333 | SEC↗ |
| Manke Isaac | Director | A Award | 2025-12-31 | 2026-01-02 | 5,258 | — | $0 | 20,583 | SEC↗ |
| Mathers Edward T | Director | A Award | 2025-12-31 | 2026-01-02 | 3,911 | — | $0 | 15,310 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | S Sale | 2025-12-22 | 2025-12-23 | 302 | $2.97 | $897 | 16,301 | SEC↗ |
| Saccomano Nicholas A | President and CEO | S Sale | 2025-12-22 | 2025-12-23 | 87 | $2.97 | $258 | 7,419 | SEC↗ |
| Manke Isaac | Director | A Award | 2025-09-30 | 2025-10-02 | 5,545 | — | $0 | 15,325 | SEC↗ |
| Mathers Edward T | Director | A Award | 2025-09-30 | 2025-10-02 | 4,125 | — | $0 | 11,399 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | S Sale | 2025-09-22 | 2025-09-24 | 303 | $2.62 | $794 | 12,603 | SEC↗ |
| Saccomano Nicholas A | President and CEO | S Sale | 2025-09-22 | 2025-09-24 | 88 | $2.62 | $231 | 3,506 | SEC↗ |
| Manke Isaac | Director | A Award | 2025-06-30 | 2025-07-02 | 6,311 | — | $0 | 9,780 | SEC↗ |
| Mathers Edward T | Director | A Award | 2025-06-30 | 2025-07-02 | 4,694 | — | $0 | 7,274 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | S Sale | 2025-06-23 | 2025-06-25 | 303 | $2.38 | $721 | 12,906 | SEC↗ |
| Saccomano Nicholas A | President and CEO | S Sale | 2025-06-23 | 2025-06-25 | 88 | $2.38 | $209 | 3,594 | SEC↗ |
| Carruthers R Michael | Director | A Award deriv | 2025-05-28 | 2025-05-30 | 7,650 | — | $0 | 7,650 | SEC↗ |
| GREY MICHAEL G | Director | A Award deriv | 2025-05-28 | 2025-05-30 | 7,650 | — | $0 | 7,650 | SEC↗ |
| Jansen Valerie Malyvanh | Director | A Award deriv | 2025-05-28 | 2025-05-30 | 7,650 | — | $0 | 7,650 | SEC↗ |
| Manke Isaac | Director | A Award deriv | 2025-05-28 | 2025-05-30 | 7,650 | — | $0 | 7,650 | SEC↗ |
| Phillips Andrew John | Director | A Award deriv | 2025-05-28 | 2025-05-30 | 7,650 | — | $0 | 7,650 | SEC↗ |
| Mathers Edward T | Director | A Award deriv | 2025-05-28 | 2025-05-30 | 7,650 | — | $0 | 7,650 | SEC↗ |
| ACORN CAPITAL ADVISORS GP, LLC | 10% Owner | P Buy | 2025-05-15 | 2025-05-19 | 270,270 | $1.85 | $500.0K | 1,709,944 | SEC↗ |
| ACORN CAPITAL ADVISORS GP, LLC | 10% Owner | P Buy | 2025-05-15 | 2025-05-19 | 1,129,730 | $1.85 | $2.09M | 1,129,730 | SEC↗ |
| Cormorant Private Healthcare F | Other | S Sale | 2025-05-15 | 2025-05-19 | 1,813,439 | $1.85 | $3.35M | 0 | SEC↗ |
| Cormorant Global Healthcare Ma | 10% Owner | S Sale | 2025-05-12 | 2025-05-14 | 24,300 | $1.99 | $48.4K | 1,813,439 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | S Sale | 2025-04-07 | 2025-04-08 | 1,844 | $2.67 | $4.9K | 13,209 | SEC↗ |
| Saccomano Nicholas A | President and CEO | S Sale | 2025-04-07 | 2025-04-08 | 516 | $2.67 | $1.4K | 3,682 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | S Sale | 2025-04-04 | 2025-04-08 | 1,278 | $3.33 | $4.3K | 15,053 | SEC↗ |
| Saccomano Nicholas A | President and CEO | S Sale | 2025-04-04 | 2025-04-08 | 358 | $3.33 | $1.2K | 4,198 | SEC↗ |
| Manke Isaac | Director | A Award | 2025-03-31 | 2025-04-02 | 3,469 | — | $0 | 3,469 | SEC↗ |
| Mathers Edward T | Director | A Award | 2025-03-31 | 2025-04-02 | 2,580 | — | $0 | 2,580 | SEC↗ |
| Agresta Samuel | Chief Medical Officer | A Award deriv | 2025-01-27 | 2025-01-29 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Hartley Dylan | Chief Scientific Officer | A Award deriv | 2025-01-27 | 2025-01-29 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | A Award deriv | 2025-01-27 | 2025-01-29 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Saccomano Nicholas A | President and CEO | A Award deriv | 2025-01-27 | 2025-01-29 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Leonard Braden Michael | Other | J Other | 2024-10-07 | 2024-10-09 | 345,739 | — | $0 | 345,739 | SEC↗ |
| Leonard Braden Michael | Other | J Other | 2024-10-07 | 2024-10-09 | 102,076 | — | $0 | 102,076 | SEC↗ |
| Agresta Samuel | Chief Medical Officer | A Award deriv | 2024-10-04 | 2024-10-08 | 18,588 | — | $0 | 18,588 | SEC↗ |
| Agresta Samuel | Chief Medical Officer | A Award deriv | 2024-10-04 | 2024-10-08 | 131,396 | — | $0 | 131,396 | SEC↗ |
| Carruthers R Michael | Director | A Award deriv | 2024-10-04 | 2024-10-08 | 15,300 | — | $0 | 15,300 | SEC↗ |
| Carruthers R Michael | Director | A Award deriv | 2024-10-04 | 2024-10-08 | 1,324 | — | $0 | 1,324 | SEC↗ |
| Carruthers R Michael | Director | A Award deriv | 2024-10-04 | 2024-10-08 | 1,760 | — | $0 | 1,760 | SEC↗ |
| GREY MICHAEL G | Director | A Award deriv | 2024-10-04 | 2024-10-08 | 15,300 | — | $0 | 15,300 | SEC↗ |
| Hartley Dylan | Chief Scientific Officer | A Award deriv | 2024-10-04 | 2024-10-08 | 137,603 | — | $0 | 137,603 | SEC↗ |
| Jansen Valerie Malyvanh | Director | A Award deriv | 2024-10-04 | 2024-10-08 | 15,300 | — | $0 | 15,300 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | A Award deriv | 2024-10-04 | 2024-10-08 | 5,322 | — | $0 | 5,322 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | A Award deriv | 2024-10-04 | 2024-10-08 | 130,611 | — | $0 | 130,611 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | A Award deriv | 2024-10-04 | 2024-10-08 | 5,781 | — | $0 | 5,781 | SEC↗ |
| Manke Isaac | Director | A Award deriv | 2024-10-04 | 2024-10-08 | 15,300 | — | $0 | 15,300 | SEC↗ |
| Mathers Edward T | Director | A Award deriv | 2024-10-04 | 2024-10-08 | 15,300 | — | $0 | 15,300 | SEC↗ |
| Phillips Andrew John | Director | A Award deriv | 2024-10-04 | 2024-10-08 | 15,300 | — | $0 | 15,300 | SEC↗ |
| Saccomano Nicholas A | President and CEO | A Award deriv | 2024-10-04 | 2024-10-08 | 2,359 | — | $0 | 2,359 | SEC↗ |
| Saccomano Nicholas A | President and CEO | A Award deriv | 2024-10-04 | 2024-10-08 | 16,898 | — | $0 | 16,898 | SEC↗ |
| Saccomano Nicholas A | President and CEO | A Award deriv | 2024-10-04 | 2024-10-08 | 8,449 | — | $0 | 8,449 | SEC↗ |
| Saccomano Nicholas A | President and CEO | A Award deriv | 2024-10-04 | 2024-10-08 | 542,232 | — | $0 | 542,232 | SEC↗ |
| Saccomano Nicholas A | President and CEO | A Award deriv | 2024-10-04 | 2024-10-08 | 1,485 | — | $0 | 1,485 | SEC↗ |
| Carruthers R Michael | Director | A Award | 2024-10-04 | 2024-10-08 | 874 | — | $0 | 874 | SEC↗ |
| Carruthers R Michael | Director | A Award | 2024-10-04 | 2024-10-08 | 4,065 | — | $0 | 4,939 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | A Award | 2024-10-04 | 2024-10-08 | 16,331 | — | $0 | 16,331 | SEC↗ |
| Saccomano Nicholas A | President and CEO | A Award | 2024-10-04 | 2024-10-08 | 4,556 | — | $0 | 4,556 | SEC↗ |